UNH Stock Risk & Deep Value Analysis
UnitedHealth Group Inc
Healthcare • Healthcare Plans
DVR Score
out of 10
What You Need to Know About UNH Stock
We analyzed UnitedHealth Group Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran UNH through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Moderate. Here's what we found.
UNH Risk Analysis & Red Flags
What Could Go Wrong
The ongoing DOJ criminal and civil investigation, if it leads to significant penalties, forced divestitures, or operational restrictions, could severely impact Optum's growth trajectory and UNH's overall profitability. This could jeopardize a portion of Optum's projected high-single-digit revenue growth over the next 3-5 years, which is a key driver for UNH's overall performance.
Risk Matrix
Overall
Moderate
Financial
Low
Market
Medium
Competitive
Low
Execution
Low
Regulatory
High
Red Flags
- ⚠
DOJ criminal and civil investigation: Presents an unquantified but potentially significant regulatory overhang impacting future M&A and operational freedom, particularly for the high-growth Optum segment.
- ⚠
Reported membership contracting by 1.3 million in 2026 (from secondary source): If verified in future filings, this would signal potential market share loss for UnitedHealthcare, impacting its primary revenue stream.
- ⚠
Very low insider ownership (0.28%): While common for mega-caps, it suggests less direct alignment with growth incentives compared to high-growth, founder-led companies.
Upcoming Risk Events
- 📅
Q2 2026 Earnings Report (July 16, 2026): A significant miss on Optum revenue or a sharper-than-expected rise in the medical loss ratio could lead to a -5% to -8% stock price correction.
- 📅
DOJ Investigation Outcome (Timeline uncertain): Any adverse ruling or significant fines from the DOJ investigation could impact Optum's business model or future acquisition strategy, potentially causing a -10% to -15% share price decline and increased regulatory scrutiny.
When to Reconsider
- 🚪
Exit if Optum's year-over-year revenue growth decelerates to below 8% for two consecutive quarters, indicating a loss of its primary growth engine.
- 🚪
Sell if the company announces significant, material financial penalties or operational restrictions as a result of the DOJ investigation.
- 🚪
Exit if UnitedHealthcare's medical loss ratio (MLR) consistently rises by more than 150 basis points year-over-year, signaling deteriorating profitability in its core insurance business.
Unlock UNH Risk Analysis & Red Flags
Create a free account to see the full analysis
What Does UnitedHealth Group Inc (UNH) Do?
Market Cap
$365.53B
Sector
Healthcare
Industry
Healthcare Plans
Employees
400,000
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older; Medicaid plans, children's health insurance and health care programs; and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
Visit UnitedHealth Group Inc WebsiteInvestment Thesis
If Optum continues to expand its health services and technology footprint at high-single-digit to low-double-digit rates, while UnitedHealthcare maintains stable profitability and manages its medical loss ratio, then UNH will deliver consistent EPS growth (high-single digits) and dividend increases. This makes UNH a reliable compounder for long-term capital appreciation and income, not a high-growth 10x opportunity, particularly for investors seeking defensive exposure to a growing healthcare market.
Is UNH Stock Undervalued?
Unlock the full AI analysis for UNH
Get the complete DVR score, risk analysis, and more
Unlock the full report
Create a free account to see the DVR score, risk flags, and AI analysis.
UNH Price Targets & Strategy
12-Month Target
$435.00
Bull Case
$460.00
Bear Case
$380.00
Valuation Basis
21x forward P/E applied to estimated FY2026 adjusted EPS of $20.70
Entry Strategy
For long-term investors seeking stable compounders, consider dollar-cost averaging on dips below $400, targeting support zones around $390-$400.
Exit Strategy
Take profit at $450-$460, representing the higher end of analyst targets. Set a stop loss at $370 if regulatory risks or membership declines materialize significantly.
Portfolio Allocation
2-4% for moderate risk tolerance, 1-2% for conservative, given its stability and dividend income.
Price Targets & Strategy
Sign up free to unlock price targets and entry/exit strategies
Is UNH Financially Healthy?
Valuation
P/E Ratio
30.35
Forward P/E
18.20
EV/EBITDA
16.80
PEG Ratio
1.90
Price/Book
6.40
Price/Sales
0.80
Profitability
Gross Margin
18.50%
Operating Margin
4.12%
Net Margin
2.68%
Return on Equity
12.40%
Revenue Growth
9.67%
EPS
$13.24
Balance Sheet
Current Ratio
0.89
Quick Ratio
0.67
Debt/Equity
0.83
Total Debt
$72.10B
Cash & Equivalents
$25.60B
Cash Flow
Operating Cash Flow
$21.60B
Free Cash Flow
$16.10B
EBITDA
$30.10B
Other
Beta (Volatility)
0.63
Dividend Yield
2.34%
Does UNH Have a Competitive Moat?
Sign in to unlockMoat Rating
🏰 Wide
Moat Trend
Stable to Expanding
Moat Sources
4 Identified
UNH's moat is highly durable, stemming from its massive scale, entrenched relationships within the complex healthcare ecosystem, and the high regulatory barriers to entry. The integrated model further strengthens its position by creating switching costs and leveraging proprietary data.
Moat Erosion Risks
- •Significant government policy changes (e.g., single-payer system, major shifts in ACA) that could disrupt the entire private insurance industry model.
- •Antitrust scrutiny (DOJ investigation) potentially limiting future M&A, particularly for Optum, which is crucial for moat expansion.
UNH Competitive Moat Analysis
Sign up to see competitive advantages
UNH Market Intelligence
Sentiment & Insider Activity
Social Sentiment
Neutral. As a large-cap, established company, UNH typically generates consistent, rather than viral, social media discussion, often focused on healthcare policy or earnings.
Institutional Sentiment
Positive. Evidenced by Goldman Sachs adding UNH to its U.S. Conviction Buy list (May 1, 2026) and Truist raising its target to $440 (June 1, 2026), alongside a 'Moderate Buy' consensus from analysts.
Insider Activity (Form 4)
Insiders own 0.28% of the company. Form 4 filings were referenced in early June 2026, but specific details on buy/sell transactions (names, titles, share counts, values) were not provided in the supplied research.
Options Flow
Normal options activity. No specific unusual options flow data was provided in the research to indicate significant institutional positioning beyond typical hedging or income generation strategies.
Earnings Intelligence
Next Earnings
2026-07-16 (Q2 2026, before market open)
Surprise Probability
Medium. UNH frequently beats adjusted EPS expectations, as seen with Q1 2026 adjusted EPS of $7.23, but its large size means revenue surprises are less volatile.
Historical Earnings Pattern
UNH typically sees a moderate positive stock price reaction (2-5% move) on earnings beats, especially if accompanied by strong guidance or Optum segment outperformance. Negative reactions are usually tied to medical loss ratio increases or conservative guidance.
Key Metrics to Watch
Competitive Position
Top Competitor
ELV (Elevance Health)
Market Share Trend
Stable to slightly gaining in specific Optum segments, but facing competitive pressures and reported declines in some UnitedHealthcare membership areas for 2026.
Valuation vs Peers
Trading at a slight premium to the average managed care sector on a forward P/E basis (approx. 21x vs sector average around 18-20x), justified by its diversified Optum segment and consistent growth.
Competitive Advantages
- •Integrated model (UnitedHealthcare + Optum) offering comprehensive health benefits and services, driving efficiency and data insights.
- •Significant scale and vast data assets, providing cost advantages and powerful analytics for care management.
- •Strong brand recognition and established payer relationships built over decades.
Market Intelligence
Sign up free to unlock sentiment, earnings intel, and peer analysis
What Could Drive UNH Stock Higher?
Near-Term (0-6 months)
- •Q2 2026 Earnings Report (July 16, 2026, before market open): Beat on Optum revenue growth and a positive revision to full-year EPS guidance above $21.00 would provide a modest boost.
- •Q2 2026 Dividend Payment ($2.32 per share, June 23, 2026): Continued dividend growth reinforces investor confidence in capital allocation and stability.
Medium-Term (6-18 months)
- •Optum's Geographic Expansion (FY2027): Successful entry into specific new international markets for Optum Health or Optum Insight, targeting a 5-10% increase in Optum's international revenue by mid-2027.
- •Resolution of DOJ Investigation (H2 2026 - H1 2027): A clear resolution without significant penalties or structural changes could remove an overhang and lead to a modest re-rating, particularly for Optum's M&A activity.
Long-Term (18+ months)
- •Enhanced Data Analytics and AI Integration (FY2028-2029): Leveraging Optum's data to drive significant cost efficiencies (e.g., 2% reduction in medical loss ratio) and personalized care, cementing market leadership and improving margins.
- •Strategic M&A in Value-Based Care (FY2028-2029): Targeted acquisitions that expand Optum's footprint in high-growth value-based care models, potentially adding $5-10B in annualized revenue through synergy-driven deals.
Catalysts & Growth Drivers
Sign up free to see growth catalysts
What's the Bull Case for UNH?
- ✓
Watch Optum segment revenue growth and operating margin: A sustained decline below 8% growth or margin compression would challenge the core growth thesis.
- ✓
Monitor UnitedHealthcare's total domestic medical membership and medical loss ratio: Any significant, sustained contraction in membership or increase in MLR could erode profitability.
- ✓
Track news and outcomes regarding the DOJ criminal and civil investigation: An adverse outcome could trigger a fundamental re-evaluation of the investment thesis.
Bull Case Analysis
Sign up free to see the bull case
Competing with UNH
See how UnitedHealth Group Inc compares to related companies
| Company | Market Cap | DVR Score | P/E | Revenue | Profit Margin | Rev Growth | |
|---|---|---|---|---|---|---|---|
UnitedHealth Group Inc UNH | $365.5B | 0.3 | 30.3 | $447.6B | 2.7% | 9.7% | |
AbbVie Inc ABBV | $381.1B | 0.1 | 104.8 | $15.0B | 5.8% | 9.5% | Compare → |
Johnson & Johnson JNJ | $557.1B | 1.0 | 26.5 | — | 21.8% | 7.9% | Compare → |
Eli Lilly and Co LLY | $965.0B | 0.5 | 52.6 | — | — | — | Compare → |
Pfizer Inc PFE | $146.4B | 4.0 | 19.5 | $62.6B | 11.8% | 1.4% | Compare → |
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
How UnitedHealth Group Inc Makes Money
UnitedHealth Group makes money primarily through two complementary segments: UnitedHealthcare, which provides health insurance and benefits to individuals, employers, and government programs, collecting premiums in exchange for covering medical costs; and Optum, which offers a broad range of health services, including pharmacy benefits management, data analytics, technology solutions, and direct patient care (e.g., physician groups and clinics). This integrated model allows UNH to manage healthcare costs more efficiently, provide comprehensive solutions, and leverage data insights across the entire healthcare continuum.
Read Full Business Model BreakdownFAQ
What is the DVR Score for UnitedHealth Group Inc (UNH)?
As of June 12, 2026, UnitedHealth Group Inc has a DVR Score of 0.3 out of 10, placing it in the "Distressed" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.
What is the market capitalization of UnitedHealth Group Inc?
UnitedHealth Group Inc's market capitalization is approximately $365.5B. The company operates in the Healthcare sector within the Healthcare Plans industry.
What ticker symbol does UnitedHealth Group Inc use?
UNH is the ticker symbol for UnitedHealth Group Inc. The company trades on the NYQ.
What is the risk level for UNH stock?
Our analysis rates UnitedHealth Group Inc's overall risk as Moderate. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.
What is the P/E ratio of UNH?
UnitedHealth Group Inc currently has a price-to-earnings (P/E) ratio of 30.3. This is above the market average, suggesting the stock may be priced for high growth expectations.
Does UnitedHealth Group Inc pay a dividend?
Yes, UnitedHealth Group Inc pays a dividend with a current yield of approximately 2.34%.
Is UnitedHealth Group Inc's revenue growing?
UnitedHealth Group Inc has reported revenue growth of 9.7%. The company is growing at a moderate pace.
Is UNH stock profitable?
UnitedHealth Group Inc has a profit margin of 2.7%. The company is profitable but margins are modest.
How often is the UNH DVR analysis updated?
Our AI-powered analysis of UnitedHealth Group Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on June 12, 2026.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for UNH (UnitedHealth Group Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.